Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $46.42 USD
Change Today -2.26 / -4.64%
Volume 1.4M
As of 4:15 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

perkinelmer inc (PKI) Snapshot

Open
$47.74
Previous Close
$48.68
Day High
$47.90
Day Low
$46.23
52 Week High
06/26/15 - $54.45
52 Week Low
10/15/14 - $38.96
Market Cap
5.3B
Average Volume 10 Days
970.2K
EPS TTM
$1.57
Shares Outstanding
113.4M
EX-Date
10/14/15
P/E TM
29.7x
Dividend
$0.28
Dividend Yield
0.60%
Current Stock Chart for PERKINELMER INC (PKI)

perkinelmer inc (PKI) Related Businessweek News

No Related Businessweek News Found

perkinelmer inc (PKI) Details

PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerate the discovery and development of critical new therapies. It provides early detection for genetic disorders from pregnancy to early childhood, well as flat panel X-ray detectors and infectious disease testing for the diagnostics market; and a suite of solutions, including reagents, liquid handling systems, and detection and imaging technologies that enable scientists to enhance life sciences research and drug discovery processes. This segment’s research portfolio includes instrumentation for automation and detection solutions, and in vitro and in vivo imaging and analysis hardware and software; and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides products, services, and solutions to facilitate the creation of safer food and consumer products. It develops and provides analytical technologies, solutions, and services that enable its customers to understand the characterization and health of various aspects, including air, water, soil, and food. This segment also provides analytical instrumentation for the industrial market, which includes the chemical, petrochemical, lubricant, polymer, electronics, pharmaceutical, and food and dietary supplement industries; and laboratory services. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer Inc. was formerly known as EG&G, Inc. and changed its name to PerkinElmer, Inc. in October, 1999. The company was founded in 1931 and is headquartered in Waltham, Massachusetts.

7,700 Employees
Last Reported Date: 02/24/15
Founded in 1931

perkinelmer inc (PKI) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $1.0M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $492.3K
Senior Vice President and President of Enviro...
Total Annual Compensation: $400.0K
Senior Vice President and President of Human ...
Total Annual Compensation: $383.1K
Senior Vice President of Administration, Gene...
Total Annual Compensation: $410.4K
Compensation as of Fiscal Year 2014.

perkinelmer inc (PKI) Key Developments

PerkinElmer Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015

PerkinElmer Inc. reported consolidated earnings results for the second quarter and six months ended June 28, 2015. For the quarter, the company’s revenue was USD 563,906,000 against USD 556,170,000 a year ago. Operating income from continuing operations was USD 68,131,000 against USD 69,637,000 a year ago. Income from continuing operations before income taxes was USD 57,288,000 against USD 60,673,000 a year ago. Income from continuing operations was USD 48,996,000 or USD 0.43 per diluted share against USD 52,003,000 or USD 0.46 per diluted share a year ago. Net income was USD 48,974,000 or USD 0.43 per diluted share against USD 50,490,000 or USD 0.44 per diluted share a year ago. Adjusted Revenue was USD 564,101,000 against USD 556,596,000 a year ago. Adjusted operating income was USD 95,844,000 against USD 93,276,000 a year ago. Net cash provided by operating activities was USD 63,471,000 against USD 54,395,000 a year ago. Capital expenditures were USD 5,620,000 against USD 8,427,000 a year ago. Adjusted EPS was USD 0.60 against USD 0.59 a year ago. For the six months, the company’s revenue was USD 1,090,807,000 against USD 1,086,780,000 a year ago. Operating income from continuing operations was USD 125,512,000 against USD 121,399,000 a year ago. Income from continuing operations before income taxes was USD 105,248,000 against USD 101,146,000 a year ago. Income from continuing operations was USD 89,307,000 or USD 0.79 per diluted share against USD 86,954,000 or USD 0.76 per diluted share a year ago. Net income was USD 89,308,000 or USD 0.79 per diluted share against USD 84,714,000 or USD 0.74 per diluted share a year ago. Adjusted Revenue was USD 1,091,271,000 against USD 1,088,658,000 a year ago. Adjusted operating income was USD 178,642,000 against USD 172,690,000 a year ago. Net cash provided by operating activities was USD 101,134,000 against USD 122,106,000 a year ago. Capital expenditures were USD 10,099,000 against USD 14,447,000 a year ago. Adjusted EPS was USD 1.10 against USD 1.05 a year ago. For the full year 2015, the company now forecasts GAAP earnings per share from continuing operations in the range of USD 2.00 to USD 2.05 and on a non-GAAP basis, which is expected to include adjusted earnings per share in the range of USD 2.55 to USD 2.60 representing 13-15% constant currency adjusted earnings per share growth. The company expects revenues for the year to be in the range of USD 2.25 billion to USD 2.3 billion, which represents approximately 7% constant currency growth at the midpoint. Net interest expense is expected to be approximately USD 42 million to USD 44 million and its adjusted tax rate is expected to be 21% with a flat weighted average share count of approximately 113.5 million shares. For the third quarter of 2015, the company expects revenues to be in the range of USD 550 million to USD 560 million, which represents approximately 7% constant currency revenue growth and organic revenue growth of 4% to 5%. Adjusted earnings per share is expected to be in the range of USD 0.58 to USD 0.60, which represents 12% constant currency adjusted earnings growth at the midpoint.

Perkinelmer Inc. Declares Quarterly Cash Dividend, Payable on November 10, 2015

The board of directors of PerkinElmer Inc. declared a regular quarterly dividend of $0.07 per share of common stock on July 22, 2015. This dividend is payable on November 10, 2015 to all shareholders of record at the close of business on October 16, 2015.

PerkinElmer Inc. to Report Q2, 2015 Results on Jul 30, 2015

PerkinElmer Inc. announced that they will report Q2, 2015 results at 5:00 PM, US Eastern Standard Time on Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PKI:US $46.42 USD -2.26

PKI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $51.20 USD -0.77
QIAGEN NV €22.74 EUR -0.66
Shimadzu Corp ¥1,700 JPY -85.00
Sirona Dental Systems Inc $93.05 USD -2.33
Teleflex Inc $126.55 USD -4.25
View Industry Companies
 

Industry Analysis

PKI

Industry Average

Valuation PKI Industry Range
Price/Earnings 34.4x
Price/Sales 2.5x
Price/Book 2.6x
Price/Cash Flow 34.6x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERKINELMER INC, please visit www.perkinelmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.